{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:34:20Z","timestamp":1760866460044,"version":"3.41.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To understand the baseline and longitudinal microperimetry characteristics in foveal-sparing atrophic late-onset retinal degeneration.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method:<\/jats:title>\n            <jats:p>Prospective, cross-sectional, longitudinal study in which patients from the retina clinics of two academic teaching hospitals were included. Mesopic microperimetry was performed using a Nidek MP-1 micro-perimeter. Mean total, foveal, inner ring, and outer ring sensitivities were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 20 eyes from 10 patients had baseline data. The subset of 10 eyes from five patients had follow-up data. The mean baseline macular sensitivity was 10.02 dB (\u00b1 5.26) with findings showing symmetry between both eyes. In the follow-up cohort, there was a significant loss of outer ring (0.83 dB per year; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0001), inner ring (0.67 dB per year; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.034), and foveal sensitivity (0.92 dB loss per year; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.015), whereas the mean sensitivity decreased significantly (0.66 dB per year; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0008) at 4-year follow-up. The drop in mean sensitivity was associated with significant increases in the number of deep scotoma points (6.20, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.037) and a decrease in the number of normal points (\u22126.30, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.022).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Microperimetry is a useful tool for macular function follow-up to measure disease progression in late-onset retinal degeneration.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003849","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T07:54:46Z","timestamp":1685692486000},"page":"1590-1596","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["MICROPERIMETRY IN FOVEAL-SPARING ATROPHIC LATE-ONSET RETINAL DEGENERATION"],"prefix":"10.1097","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1612-293X","authenticated-orcid":false,"given":"Varsha","family":"Alex","sequence":"first","affiliation":[{"name":"Viterbi Family Department of Ophthalmology, Shiley Eye Institute, UCSD, La Jolla, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios","family":"Papastavrou","sequence":"additional","affiliation":[{"name":"Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan H.","family":"Walker","sequence":"additional","affiliation":[{"name":"Viterbi Family Department of Ophthalmology, Shiley Eye Institute, UCSD, La Jolla, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C.","family":"Browning","sequence":"additional","affiliation":[{"name":"Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baljean","family":"Dhillon","sequence":"additional","affiliation":[{"name":"Centre for Clinical Brain Sciences, School of Clinical Sciences, College of Medicine and Veterinary Medicine, University of Edinburgh, Scotland, United Kingdom; and"},{"name":"Princess Alexandra Eye Pavilion, Chalmers Street, Edinburgh, Scotland, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyamanga","family":"Borooah","sequence":"additional","affiliation":[{"name":"Viterbi Family Department of Ophthalmology, Shiley Eye Institute, UCSD, La Jolla, California;"},{"name":"Centre for Clinical Brain Sciences, School of Clinical Sciences, College of Medicine and Veterinary Medicine, University of Edinburgh, Scotland, United Kingdom; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/hmg\/ddg289","article-title":"Mutation in a short-chain collagen gene, CTRP5, results in extracellular deposit formation in late-onset retinal degeneration: a genetic model for age-related macular degeneration","volume":"12","author":"Hayward","year":"2003","journal-title":"Hum Mol Genet"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"e13011","DOI":"10.1111\/acel.13011","article-title":"Late-onset retinal degeneration pathology due to mutations in CTRP5 is mediated through HTRA1","volume":"18","author":"Chekuri","year":"2019","journal-title":"Aging Cell"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/sj.eye.6700408","article-title":"The diagnosis of autosomal dominant late-onset retinal degeneration in two sisters","volume":"17","author":"Styles","year":"2003","journal-title":"Eye"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/bjo.2008.150151","article-title":"Late-onset retinal macular degeneration: clinical insights into an inherited retinal degeneration","volume":"85","author":"Borooah","year":"2009","journal-title":"Postgrad Med J"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/aos.12010","article-title":"Phenotypic findings in C1QTNF5 retinopathy (late-onset retinal degeneration)","volume":"91","author":"Soumplis","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"R6-20250605","first-page":"1882","article-title":"Phenotypic marker for early disease detection in dominant late-onset retinal degeneration","volume":"42","author":"Jacobson","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/IAE.0000000000003017","article-title":"Characterizing the natural history of foveal-sparing atrophic late-onset retinal degeneration","volume":"41","author":"Borooah","year":"2021","journal-title":"Retina"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/IAE.0b013e318240a574","article-title":"The characterization of retinal phenotype in a family with C1QTNF5-related late-onset retinal degeneration","volume":"32","author":"Vincent","year":"2012","journal-title":"Retina"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/jamaophthalmol.2014.2059","article-title":"Late-Onset retinal degeneration caused by C1QTNF5 mutation: sub\u2013retinal pigment epithelium deposits and visual consequences","volume":"132","author":"Jacobson","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1097\/IAE.0000000000001113","article-title":"Longitudinal structural changes in late-onset retinal degeneration","volume":"36","author":"Cukras","year":"2016","journal-title":"Retina"},{"key":"R11-20250605","first-page":"2836","article-title":"Exploratory safety profile of EDIT-101, a first-in-human in vivo CRISPR gene editing therapy for CEP290-related retinal degeneration","volume":"63","author":"Jaskolka","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-02872-x","article-title":"AMPK modulation ameliorates dominant disease phenotypes of CTRP5 variant in retinal degeneration","volume":"4","author":"Miyagishima","year":"2021","journal-title":"Commun Biol"},{"key":"R13-20250605","first-page":"1368","article-title":"Late-onset retinal macular degeneration: refining the phenotype","volume":"54","author":"Borooah","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jamaophthalmol.2020.1735","article-title":"Longitudinal microperimetric changes of macular sensitivity in Stargardt disease after 12 months: ProgStar Report No. 13","volume":"138","author":"Sch\u00f6nbach","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.ophtha.2014.06.032","article-title":"Macular function and morphologic features in juvenile stargardt disease: longitudinal study","volume":"121","author":"Testa","year":"2014","journal-title":"Ophthalmology"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1167\/iovs.11-8415","article-title":"Macular function in macular degenerations: repeatability of microperimetry as a potential outcome measure for ABCA4-associated retinopathy trials","volume":"53","author":"Cideciyan","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bjophthalmol-2018-312253","article-title":"Optimisation of dark adaptation time required for mesopic microperimetry","volume":"103","author":"Han","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/IAE.0000000000001706","article-title":"Correlation of structural and functional outcome measures in a phase one trial of ciliary neurotrophic factor in type 2 idiopathic macular telangiectasia","volume":"38","author":"Sallo","year":"2018","journal-title":"Retina"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1167\/iovs.08-2032","article-title":"Reading performance is reduced by parafoveal scotomas in patients with macular telangiectasia type 2","volume":"50","author":"Finger","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1167\/iovs.08-2926","article-title":"Test\u2013retest variability of microperimetry using the Nidek MP1 in patients with macular disease","volume":"50","author":"Chen","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00417-016-3466-z","article-title":"Long-term longitudinal modifications in mesopic MP in early and intermediate age-related macular degeneration","volume":"255","author":"Vujosevic","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamaophthalmol.2017.1162","article-title":"Macular sensitivity measured with MP in stargardt disease in the progression of atrophy secondary to stargardt disease (ProgStar) study: report No. 7","volume":"135","author":"Sch\u00f6nbach","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/IAE.0b013e31816690bd","article-title":"Retinal function and loss of autofluorescence in Stargardt disease","volume":"28","author":"Sunness","year":"2008","journal-title":"Retina"},{"key":"R24-20250605","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.oret.2020.12.012","article-title":"Reticular pseudodrusen in late-onset retinal degeneration","volume":"5","author":"Borooah","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"R25-20250605","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41433-019-0348-8","article-title":"Multimodal imaging of late-onset retinal degeneration complicated by bilateral choroidal neovascularization","volume":"33","author":"Mandal","year":"2019","journal-title":"Eye"},{"key":"R26-20250605","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000515148","article-title":"Clinical perspectives and trends: microperimetry as a trial endpoint in retinal disease","volume":"244","author":"Yang","year":"2021","journal-title":"Ophthalmologica"},{"key":"R27-20250605","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/ICB.0b013e31806011e6","article-title":"What you see is not always what you get in atrophic macular disease","volume":"2","author":"Sunness","year":"2008","journal-title":"Retina Cases Brief Rep"},{"key":"R28-20250605","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/ICB.0000000000001067","article-title":"The progression of macular structural and functional changes in late-onset retinal degeneration","volume":"16","author":"Papastavrou","year":"2022","journal-title":"Retin Cases Brief Rep"},{"key":"R29-20250605","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ajo.2021.07.032","article-title":"Visual dysfunction and structural correlates in Sorsby fundus dystrophy","volume":"234","author":"Raming","year":"2022","journal-title":"Am J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:09:39Z","timestamp":1749143379000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003849","relation":{},"ISSN":["0275-004X"],"issn-type":[{"type":"print","value":"0275-004X"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}